Variant report
Variant | esv3337891 |
---|---|
Chromosome Location | chr3:158813058-158819906 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559014781 | chr3:158819008-158819009 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529845566 | chr3:158819012-158819013 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549290071 | chr3:158819019-158819020 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371851916 | chr3:158819025-158819026 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374815943 | chr3:158819031-158819032 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369165707 | chr3:158819035-158819036 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369536962 | chr3:158819041-158819042 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373339273 | chr3:158819046-158819047 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs568257208 | chr3:158819052-158819053 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377519595 | chr3:158819053-158819054 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs111393246 | chr3:158819067-158819068 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550467902 | chr3:158819101-158819102 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139200163 | chr3:158819120-158819121 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538992678 | chr3:158819123-158819124 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141727428 | chr3:158819129-158819130 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373881554 | chr3:158819146-158819147 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147203456 | chr3:158819147-158819148 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182907414 | chr3:158819161-158819162 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9825539 | chr3:158819162-158819163 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs144263366 | chr3:158819195-158819196 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs367770193 | chr3:158819220-158819221 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566482960 | chr3:158819226-158819227 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147382551 | chr3:158819252-158819253 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530213565 | chr3:158819259-158819260 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370039088 | chr3:158819290-158819291 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139005582 | chr3:158819316-158819317 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188163776 | chr3:158819321-158819322 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192373658 | chr3:158819325-158819326 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558952786 | chr3:158819340-158819341 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183623595 | chr3:158819346-158819347 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187900264 | chr3:158819355-158819356 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563260628 | chr3:158819368-158819369 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73027608 | chr3:158819382-158819383 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs538932800 | chr3:158819386-158819387 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149885522 | chr3:158819391-158819392 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs76154220 | chr3:158819416-158819417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192504871 | chr3:158819419-158819420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547789681 | chr3:158819423-158819424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566096985 | chr3:158819436-158819437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145397684 | chr3:158819469-158819470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543627253 | chr3:158819473-158819474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548619334 | chr3:158819483-158819484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184686444 | chr3:158819523-158819524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111927549 | chr3:158819543-158819544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78949390 | chr3:158819617-158819618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9826407 | chr3:158819618-158819619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542275721 | chr3:158819623-158819624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79781224 | chr3:158819624-158819625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61796008 | chr3:158819669-158819670 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs2364930 | chr3:158819701-158819702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:158819000-158819400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
2 | chr3:158819200-158819400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:158819400-158823800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |